Chang Dai

机构：Guangdong Academy of Medical Sciences · ORCID：0000-0001-7971-883X

发表论文 21 篇 · 总被引 674 次 · h-index 14

代表论文

• Ferrostatin-1 alleviates lipopolysaccharide-induced cardiac dysfunction (2021 · Bioengineered · 被引 196)
• Ferroportin-mediated ferroptosis involved in new-onset atrial fibrillation with LPS-induced endotoxemia (2021 · European Journal of Pharmacology · 被引 73)
• Inhibition of ferroptosis reduces susceptibility to frequent excessive alcohol consumption-induced atrial fibrillation (2021 · Toxicology · 被引 59)
• Concurrent Physiological and Pathological Angiogenesis in Retinopathy of Prematurity and Emerging Therapies (2021 · International Journal of Molecular Sciences · 被引 54)
• Regulatory mechanisms of Robo4 and their effects on angiogenesis (2019 · Bioscience Reports · 被引 53)
• Key Player in Cardiac Hypertrophy, Emphasizing the Role of Toll-Like Receptor 4 (2020 · Frontiers in Cardiovascular Medicine · 被引 46)